• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

VaxGen

edit

VaxGen, Inc. operates as a biopharmaceutical company in the United States. It owns a biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that could be used to make cell culture or microbial biologic products. The company was founded in 1995 and is based in South San Francisco, California.

Milestones

edit

• 
  VaxGen added James Panek as President, Chief Operating Officer.
  Posted 10/15/09 at 10:47pm
• 
  Went public with stock symbol OTCBB:VXGN.
  Posted 10/15/09 at 10:48pm
• 
  VaxGen was acquired by Oxigene for $33M. (10/1/09)
  Posted 10/15/09 at 10:54pm via fiercebiotech.com

Videos

Screenshots

edit

Stock Price

Sources

1. OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger Read more: http://www.fiercebiotech.com/press-releases/oxigene-acquire-vaxgen-stock-stock-merger#ixzz0U4z2RYEU (fiercebiotech.com) [edit]